# Glaukos Corporation - Inspection Records

Source: https://www.keypedia.com/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83

> Inspection records and compliance data for Glaukos Corporation in San Clemente, California. Access full analysis and detailed observations.

---

## Details

- Name: Glaukos Corporation
- FEI Number: 3012341472
- City: San Clemente
- State: California
- Country Name: United States
- Address Line 1: 229 Avenida Fabricante
- Zip Code: 92672

## Related Documents

- [483 - Glaukos Corporation - 2025-04-22](https://www.keypedia.com/records/483/glaukos-corporation/75592a62-0ccb-440f-b6e5-179b4bb122bd) — source: FDA, date: April 22, 2025
- [FDA Inspection 1267669 - Glaukos Corporation - 2025-04-22](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/1b4713bf-a869-4279-8c47-8e76dc9f26ea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 22, 2025
- [FDA Inspection 1251714 - Glaukos Corporation - 2024-08-15](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/b52e7c7c-618d-4cdf-b0c4-24e750c4da55) — classification: No Action Indicated (NAI), source: FDA, date: August 15, 2024
- [EIR - Glaukos Corporation - 2023-07-19](https://www.keypedia.com/records/eir/glaukos-corporation/5fa46de4-6b74-433c-9f93-15d891285975) — source: FDA, date: July 19, 2023
- [FDA Inspection 1068254 - Glaukos Corporation - 2018-08-03](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/f50203a2-aa76-4e83-a2a9-cf9662c25875) — classification: No Action Indicated (NAI), source: FDA, date: August 3, 2018
- [FDA Inspection 981961 - Glaukos Corporation - 2016-06-10](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/ef93c2ae-49ac-4cc7-b9eb-f5638468c92b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 10, 2016
- [FDA Inspection 835427 - Glaukos Corporation - 2013-06-11](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/31bb012e-6841-4b91-b6d3-ee3c6940bd08) — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2013
- [FDA Inspection 835427 - Glaukos Corporation - 2013-06-11](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/827c4c88-291b-427a-9f09-c214712ea8ff) — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2013
- [FDA Inspection 835427 - Glaukos Corporation - 2013-06-11](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/320295f5-d93e-4633-b83a-a6caacf3b5cd) — classification: No Action Indicated (NAI), source: FDA, date: June 11, 2013
- [FDA Inspection 781289 - Glaukos Corporation - 2012-05-09](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/9b06a256-daa9-435a-a5dc-b0f2bb02cabd) — classification: No Action Indicated (NAI), source: FDA, date: May 9, 2012
- [FDA Inspection 781289 - Glaukos Corporation - 2012-05-09](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/68a26c43-3345-4926-8d92-82e002163517) — classification: No Action Indicated (NAI), source: FDA, date: May 9, 2012
- [FDA Inspection 562763 - Glaukos Corporation - 2009-03-09](https://www.keypedia.com/records/fda_inspections/glaukos-corporation/4b70e833-5320-4485-be04-f8ac96580627) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2009

## Related Companies

- [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [Finish Line Horse Products, Inc.](https://www.keypedia.com/companies/finish-line-horse-products-inc/205e6869-8995-4e35-9af4-e022b2dedb77)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/b3d7bba7-bfc8-4d2b-a517-321f7b518a12)
- [Janssen Pharmaceuticals Inc.](https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Amgen Technology (Ireland) Unlimited Company](https://www.keypedia.com/companies/amgen-technology-ireland-unlimited-company/576ab93b-ec8d-4b76-b25c-a1c473d6ae61)
- [Organon Pharma (UK) Ltd.](https://www.keypedia.com/companies/organon-pharma-uk-ltd/5fa8cf74-45d3-45f6-abb3-6918d01961a6)
- [Sever Pharma Solutions](https://www.keypedia.com/companies/sever-pharma-solutions/d4aaa41d-8c80-4520-bc82-45ae10cb4795)

## Related Officers

- [recipient](https://www.keypedia.com/people/matthew-d-young/081457cf-fcbe-47b1-ab77-62df2f2342ca)
- [company_representative](https://www.keypedia.com/people/brian-wolf/30c9efb2-446a-4add-8e1b-3804b4da87ba)
- [Youkeun Kim](https://www.keypedia.com/people/youkeun-kim/94ccfde4-72f7-4df1-9c68-ede73e5e23d0)
- [Public Affairs Specialist](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)